4 results
Risk Stratification for Developing Severe Hyperbilirubinemia. Bhutani et al. Pediatrics. 1999.

In general, babies at low-risk and
Bhutani et al. ... Pediatrics. 1999 ... low-intermediate risk can ... #Peds #Pediatrics ... #Management #Neonatal
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... anti-IL6R mAb) Dose can ... Common adverse effects ... #Pharmacology # ... Management #Medications
Sedative-Hypnotic Visual Decision Aid

What would happen if 100 people over 60 years of age take sleeping
like a fall or car ... #Management #Sedatives ... #DecisionAid #Pharmacology ... #SideEffects #Adverse ... #Geriatrics
Neonatal Resuscitation – Circulation and Drugs
Consider drugs (k) if heart rate beats/min in spite of adequate
vasoconstriction may have had ... #Medications #Pharmacology ... #management #peds ... #pediatrics